Den givne dosis skal reduceres med 50% i tilfælde af forekomst af hæmatologiske lidelser (hvide blodlegemer < 1. 500/ mm3, granulocytter < 1. 000/ mm3, thrombocytter < 100. 000/ mm3).
The administered dose should be reduced by 50% in case of occurrence of haematological disorders (white blood cells < 1,500/mm3, granulocytes < 1,000/mm3, thrombocytes < 100,000/mm3).